Prostate Cancer ICD-10 Code: Complete Guide to Diagnosis and Coding

The Prostate Cancer ICD-10 code seems simple. Most healthcare professionals think of prostate cancer in terms of one diagnosis code. Accurate coding is further complicated by documentation of the site of the malignancy, disease status, screening encounters, personal history, treatment follow-up, or other prostate related disorders.

Selecting the correct ICD-10-CM code is essential for physicians, medical coders, oncology practices, urology clinics, and billing teams to ensure claim accuracy, reimbursement, and compliance. A mistake in coding might result in claim denials, medical necessity changes, delayed payments, incorrect risk adjustment and audit issues. Frequent issues involve misinterpretation of active prostate cancer vs history of prostate cancer, inappropriate coding of screening contacts, and documentation that does not justify the level of specificity stated.

Proper prostate cancer coding is not about finding the diagnosis in the record. It requires review of the provider’s notes to know if the cancer is active or if it was found in the past. Coders must look at where in the body the cancer is located. They also need to follow the ICD-10-CM guidelines and make sure the diagnosis matches the services that were provided. This matters a lot when a patient, with prostate cancer gets a biopsy an imaging test, surgery, radiation, chemotherapy, hormone therapy or ongoing cancer care.

This guide talks about the ICD-10-CM diagnosis coding for prostate cancer. It covers codes. It looks at how tumors grouped. It includes codes, for checking for cancer. It explains how to code for a history of the disease. It links to CPT codes. It discusses what needs to be written down. It covers issues with charging money for the services.

What Is the ICD-10 Code for Prostate Cancer?

The most commonly used ICD-10 code for prostate cancer is:

C61 — Malignant neoplasm of prostate

This code refers to a tumor that has been confirmed in the prostate gland. Generally when a healthcare provider writes down prostate cancer but does not give details, about the exact location the right ICD-10-CM code to use is C61.

However, C61 should only be assigned when active prostate cancer is documented. It should not be used for:

• Prostate cancer screening visits
• A past history of prostate cancer that has been treated and is no longer active
• Elevated PSA without confirmed malignancy
• Benign prostate enlargement
• Suspicious findings without a confirmed diagnosis

The correct code depends on the purpose of the encounter and the patient’s documented condition.

For example:

• A patient currently receiving radiation therapy for prostate cancer → C61
• A patient returning years after completed prostate cancer treatment with no active disease → Z85.46 (Personal history of malignant neoplasm of prostate)
• A healthy patient undergoing routine prostate cancer screening → Z12.5 (Encounter for screening for malignant neoplasm of prostate)

Understanding these differences helps prevent improper billing and coding errors.

Current ICD-10-CM Version and Coding Updates for 2026

Healthcare organizations must assign diagnoses using the ICD-10-CM code set that’s suitable, for the day the patient received care.

Doctors and coding teams need to use the FY 2026 ICD-10-CM code set for visits that happen during the year 2026. The FY 2026 ICD-10-CM code set applies to dates of service starting October 1 2025 and ending September 30 2026.

ICD-10-CM updates may introduce:

• New diagnosis codes
• Revised descriptions
• Deleted codes
• Updated instructional notes
• Coding guideline changes

Medical billing teams should not depend on code lists. Using versions can lead to problems when processing claims. It might also cause compliance issues. Staying up to date with codes is important, for accuracy and avoiding penalties.

For prostate cancer coding, the primary concept remains stable:

• C61 continues to represent malignant neoplasm of prostate.
• Screening, history, and follow-up encounters require different code selection.

The diagnosis code must always match the patient’s clinical status documented for that specific encounter.

Prostate Cancer ICD-10 Code Reference Table

The following table lists ICD‑10‑CM codes that are often used for prostate conditions, in notes and medical billing.

Understanding the Difference Between Active Cancer, History, and Screening Codes

One of the most common prostate cancer coding mistakes involves confusing active disease with historical conditions.

Active Prostate Cancer (C61)

Code C61 applies when the patient currently has prostate cancer.

Examples include:

• Newly diagnosed prostate adenocarcinoma
• Prostate cancer undergoing treatment
• Persistent disease after treatment
• Metastatic prostate cancer originating from the prostate

A provider must document the cancer diagnosis. Coders should not assign C61 solely because a patient has:

• Elevated PSA
• Abnormal imaging
• Suspicious biopsy findings without confirmed diagnosis

Personal History of Prostate Cancer (Z85.46)

The hx of prostate cancer ICD-10 code is:

Z85.46 — Personal history of malignant neoplasm of prostate

This code applies when the prostate cancer has been treated and no longer exists as an active condition.

Examples:

• Patient had prostatectomy several years ago and has no evidence of disease
• Completed radiation therapy with no current malignancy
• Follow-up visit after successful cancer treatment

Using C61 instead of Z85.46 for a history-only situation may incorrectly suggest active malignancy and can affect risk adjustment and payer review.

Prostate Cancer Screening Code (Z12.5)

The ICD-10 code for prostate cancer screening is:

Z12.5 — Encounter for screening for malignant neoplasm of prostate

This code is used when the patient does not have prostate cancer symptoms or a confirmed diagnosis and is receiving preventive screening.

Common examples:

• Annual preventive examination
• PSA screening ordered for an asymptomatic patient
• Preventive health visit

A screening code should not be used when the provider is evaluating known prostate cancer.

Neoplasm of Prostate ICD-10 Coding Explained

The phrase neoplasm of prostate ICD-10 can create confusion because not all prostate neoplasms represent cancer.

The ICD-10-CM neoplasm classification separates conditions into different categories:

Malignant Neoplasm

Malignant prostate tumors are classified under:

C00–C96: Malignant neoplasms

For prostate cancer:

C61 — Malignant neoplasm of prostate

This indicates confirmed cancer.

Benign Neoplasm

Benign tumors are classified separately.

Benign prostate conditions are generally not coded as prostate cancer.

Examples:

• Benign prostatic hyperplasia
• Nonmalignant prostate enlargement

These require different diagnosis codes.

Uncertain Behavior or Unspecified Behavior

Some abnormal growths may not yet have a confirmed malignant classification.

These conditions may fall under:

• D37–D48 categories for uncertain behavior neoplasms

The correct selection depends on provider documentation and pathology interpretation.

ICD-10 Code Selection Process for Prostate Cancer

Accurate prostate cancer coding requires a structured review process. Coders should code from provider documentation rather than making assumptions based on clinical findings.

1. Start With the Provider’s Documented Diagnosis

The first step is reviewing what the physician has clearly documented.

Examples of acceptable documentation:

• “Prostate adenocarcinoma”
• “Active prostate cancer”
• “Malignant neoplasm of prostate”
• “History of prostate cancer”

Coders should not independently interpret:

• PSA levels
• Imaging reports
• Laboratory results
• Pathology findings

unless coding guidelines specifically allow it and provider documentation supports the diagnosis.

2. Identify Whether Cancer Is Active or Historical

This is one of the most important coding decisions.

Ask:

• Is the patient currently being treated?
• Does the provider document active malignancy?
• Has treatment been completed?
• Is the visit only surveillance?

Examples:

3. Confirm the Primary Cancer Site

For prostate cancer, documentation should establish that the malignancy originates in the prostate.

Do not confuse:

• Prostate cancer
• Bladder cancer
• Kidney cancer
• Colorectal cancer

For example, the ICD-10 code for colorectal cancer is not related to prostate cancer coding.

Colorectal malignancies are coded under:

C18–C20 categories

depending on the documented location.

4. Review Documentation for Metastatic Disease

Advanced prostate cancer may spread to other areas.

When documented, secondary malignancies may require additional codes.

Examples:

• Bone metastasis → C79.51
• Other secondary malignant sites → C79.9

The primary prostate cancer code does not replace documented metastatic cancer codes when additional reporting is required.

5. Apply ICD-10-CM Guidelines and Sequencing Rules

Coding sequence depends on:

• Reason for encounter
• Treatment provided
• Active conditions documented
• Official ICD-10-CM guidelines

For example:

A radiation oncology encounter for active prostate cancer generally requires coding the malignancy being treated.

A preventive screening encounter requires a screening code.

6. Review Medical Necessity Requirements

Diagnosis codes must support the medical services billed.

Examples:

A PSA screening claim may require:

• Z12.5 for screening
• Appropriate preventive context

A cancer treatment claim may require:

• C61
• Supporting documentation
• Treatment-related diagnoses when applicable

Incorrect diagnosis selection can result in:

• Medical necessity denials
• Claim delays
• Additional documentation requests

Documentation Requirements for Accurate Prostate Cancer Coding

Accurate ICD-10-CM coding begins with complete and specific provider documentation. A medical coder cannot select the most appropriate diagnosis code if the clinical record does not clearly explain the patient’s condition, disease status, or reason for the encounter.

For prostate cancer cases, documentation affects:

• ICD-10-CM code assignment
• Medical necessity determination
• Treatment authorization
• Claim reimbursement
• Risk adjustment accuracy
• Audit defensibility

Incomplete documentation may result in coding errors such as reporting active malignancy when the patient only has a history of cancer or using a screening diagnosis when the patient is receiving cancer treatment.

Healthcare providers should clearly document the following elements.

Prostate Cancer Documentation Checklist

Common Documentation Problems That Affect Coding

Problem 1: Provider Documents Only “Prostate Cancer History”

A statement such as:

Patient with prostate cancer history presents today

does not automatically indicate active malignancy.

The coder must determine whether the provider means:

• Active prostate cancer
• Personal history of prostate cancer
• Follow-up after completed treatment

If unclear, a provider query may be required.

Problem 2: Elevated PSA Is Coded as Cancer

A common mistake is assigning a prostate cancer diagnosis based only on an elevated PSA level.

An elevated PSA does not confirm malignancy.

If prostate cancer has not been diagnosed, the appropriate diagnosis may be:

R97.20 — Elevated prostate specific antigen [PSA]

The final diagnosis must come from provider documentation.

Problem 3: Screening and Diagnostic Testing Are Mixed

Screening and diagnostic encounters have different coding purposes.

Example:

Screening Visit

Patient has no symptoms and receives routine PSA testing.

Possible diagnosis:

Z12.5 — Encounter for screening for malignant neoplasm of prostate

Diagnostic Evaluation

Patient has abnormal PSA and requires additional evaluation.

Possible diagnosis:

R97.20 — Elevated PSA

The coding depends on the reason for the encounter.

CPT Codes Commonly Associated With Prostate Cancer Care

ICD-10-CM diagnosis codes explain why a service is performed. CPT codes describe what service was provided.

For prostate cancer billing, diagnosis coding and procedure coding must work together.

The following CPT codes are commonly encountered in prostate cancer diagnosis, treatment, and monitoring.

Prostate Cancer Screening CPT Codes

CPT 84153 — Prostate Specific Antigen (PSA)

This laboratory procedure measures PSA levels in blood.

Common uses:

• Prostate cancer screening
• Monitoring after treatment
• Surveillance for recurrence

The diagnosis code supporting PSA testing depends on the clinical situation.

Examples:

Prostate Biopsy CPT Codes

When prostate cancer is suspected, providers may perform a prostate biopsy.

Common CPT codes include:

CPT 55700

Biopsy, prostate; needle or punch, single or multiple, any approach

Used for prostate tissue sampling.

CPT 76872

Transrectal ultrasound

Often performed to guide prostate evaluation or biopsy procedures.

CPT 88305

Surgical pathology examination

Used when biopsy specimens are analyzed by pathology.

The diagnosis supporting pathology services may include:

• Elevated PSA
• Abnormal prostate findings
• Confirmed prostate cancer

depending on the encounter.

Prostate Cancer Treatment CPT Codes

Radical Prostatectomy

Surgical removal of the prostate may involve codes such as:

• CPT 55866 — Laparoscopy, surgical prostatectomy, radical, including nerve sparing when performed

The diagnosis typically supporting this procedure:

• C61 — Malignant neoplasm of prostate

Radiation Therapy

Radiation oncology services may involve multiple CPT codes depending on treatment type.

Examples include:

• Radiation treatment planning
• Simulation services
• Treatment delivery
• Image guidance

The diagnosis generally requires documentation of active prostate malignancy.

Hormone Therapy and Injection Services

Advanced prostate cancer management may include androgen deprivation therapy.

Billing may involve:

• Drug administration codes
• Medication-specific HCPCS codes
• Office visit codes

Diagnosis support may include:

• C61
• Secondary metastatic cancer codes when documented

Evaluation and Management (E/M) Coding Considerations

Prostate cancer patients frequently require:

• Urology visits
• Oncology consultations
• Treatment monitoring
• Follow-up evaluations

E/M services must be supported by:

• Medical decision-making complexity
• Patient history
• Examination requirements where applicable
• Documentation requirements for the selected code level

The diagnosis code alone does not determine the E/M level.

Practical Prostate Cancer Billing Workflow

A successful prostate cancer billing process requires coordination between providers, coders, and revenue cycle teams.

Step 1: Verify Provider Documentation

Before claim submission, confirm:

• Diagnosis is clearly documented
• Cancer status is identified
• Treatment purpose is documented
• Supporting clinical information is available

Step 2: Assign the Correct ICD-10-CM Diagnosis

Examples:

Active Disease

Provider documentation:

Patient with active prostate adenocarcinoma receiving radiation treatment.

Coding:

• C61 — Malignant neoplasm of prostate

Completed Treatment

Provider documentation:

History of prostate cancer treated with prostatectomy, no evidence of disease.

Coding:

• Z85.46 — Personal history of malignant neoplasm of prostate

Screening Encounter

Provider documentation:

Annual PSA screening.

Coding:

• Z12.5 — Encounter for screening for malignant neoplasm of prostate

Step 3: Match Diagnosis With Procedure

The diagnosis must justify the billed service.

Examples:

Step 4: Review Payer Requirements

Different payers may have specific requirements regarding:

• Prior authorization
• Medical necessity documentation
• Coverage limitations
• Frequency restrictions
• Clinical notes

Billing teams should verify payer policies before submitting high-cost oncology services.

Common Prostate Cancer Coding and Billing Errors

1. Using C61 for Every Prostate Cancer-Related Visit

Not every prostate-related encounter represents active cancer.

Incorrect:

Patient treated for prostate cancer 10 years ago with no recurrence.

Reported:

C61

Correct:

Z85.46

2. Coding Screening When Cancer Is Already Diagnosed

Screening codes are for patients without confirmed disease.

Incorrect:

Patient undergoing radiation treatment for prostate cancer.

Reported:

Z12.5

Correct:

C61

3. Coding Cancer Without Provider Confirmation

A coder should not assign malignancy based on:

• PSA results
• Imaging findings
• Suspicious lesions

without provider documentation.

4. Missing Secondary Metastatic Codes

When documented, metastatic disease may require additional diagnosis coding.

Example:

Provider documents:

“Prostate cancer metastatic to bone.”

Possible coding:

• C61 — Primary prostate malignancy
• C79.51 — Secondary malignant neoplasm of bone

How Incorrect Prostate Cancer Coding Leads to Claim Denials

Incorrect diagnosis coding can trigger several payer issues.

Medical Necessity Denials

Example:

A prostate biopsy claim submitted with a screening diagnosis may not justify a diagnostic procedure.

Authorization Problems

Cancer treatments often require authorization.

Incorrect ICD-10 reporting may cause:

• Authorization rejection
• Treatment delays
• Additional documentation requests

Audit Risk

Auditors review whether:

• Documentation supports reported codes
• Diagnosis matches services performed
• Coding follows ICD-10-CM guidelines

Incorrect use of active cancer codes can create compliance concerns.

Prostate Cancer Coding Examples

Example 1: Newly Diagnosed Prostate Cancer

Documentation:

Biopsy confirms prostate adenocarcinoma. Patient scheduled for treatment planning.

Coding:

Primary diagnosis:

C61 — Malignant neoplasm of prostate

Reason:

Active confirmed malignancy.

Example 2: Follow-Up After Successful Treatment

Documentation:

Patient underwent prostatectomy five years ago. No evidence of recurrent cancer.

Coding:

Z85.46 — Personal history of malignant neoplasm of prostate

Reason:

Cancer is not currently active.

Example 3: Routine PSA Screening

Documentation:

Patient presents for annual preventive PSA screening. No symptoms.

Coding:

Z12.5 — Encounter for screening for malignant neoplasm of prostate

Reason:

Preventive screening encounter.

Example 4: Elevated PSA Investigation

Documentation:

Patient presents for evaluation of elevated PSA. Prostate biopsy planned.

Coding:

Possible diagnosis:

R97.20 — Elevated prostate specific antigen [PSA]

Reason:

Cancer has not yet been confirmed.

Advanced Prostate Cancer ICD-10 Coding Considerations

Prostate cancer coding requires careful attention because the diagnosis code represents the patient’s documented disease status, not simply a past diagnosis or clinical suspicion.

The ICD-10-CM classification separates active malignancy, screening encounters, personal history, symptoms, and related conditions. Correct reporting improves claim accuracy and ensures that healthcare data reflects the patient’s actual condition.

Coding Prostate Cancer With Metastatic Disease

When prostate cancer spreads beyond the prostate gland, coding may require reporting both:

1. The primary malignant neoplasm
2. The secondary malignant sites

The primary diagnosis remains:

C61 — Malignant neoplasm of prostate

Additional codes may be assigned when metastatic disease is documented.

Examples:

Example:

Provider documentation:

Metastatic prostate adenocarcinoma with bone involvement.

Possible coding:

• C61 — Malignant neoplasm of prostate
• C79.51 — Secondary malignant neoplasm of bone

The exact sequencing depends on the reason for the encounter and applicable coding guidelines.

Prostate Cancer After Surgery: C61 vs Z85.46

A frequent billing challenge occurs after prostatectomy.

A patient may have a previous prostate cancer diagnosis but no current evidence of malignancy.

The coding decision depends on whether the cancer remains active.

Active Cancer After Surgery

Example:

Residual prostate cancer requiring additional treatment.

Coding:

C61 — Malignant neoplasm of prostate

No Evidence of Disease After Treatment

Example:

“History of prostate cancer status post prostatectomy, PSA undetectable, no recurrence.”

Coding:

Z85.46 — Personal history of malignant neoplasm of prostate

The ICD-10 code for history of prostate cancer should be used when the malignancy has been eradicated and the patient is receiving follow-up care rather than active cancer treatment.

Prostate Cancer Active Surveillance Coding

Active surveillance creates confusion because some patients are monitored without immediate treatment.

Providers and coding teams should carefully review documentation.

Examples:

Confirmed Cancer Under Surveillance

If the physician documents active prostate cancer being monitored:

Possible coding:

C61 — Malignant neoplasm of prostate

Previous Cancer With Completed Treatment

If the patient no longer has active disease:

Possible coding:

Z85.46 — Personal history of malignant neoplasm of prostate

The distinction depends on provider documentation and clinical circumstances.

Family History of Prostate Cancer Coding

Family history is different from personal history.

A patient may have an increased risk because a close relative had prostate cancer, but the patient does not have cancer.

The ICD-10-CM code:

Z80.42 — Family history of malignant neoplasm of prostate

may be used when appropriate.

This code does not indicate that the patient has prostate cancer.

It should not replace:

C61 — Active prostate cancer

or:

Z85.46 — Personal history of prostate cancer

Common Related Diagnosis Codes Used in Urology and Oncology

Prostate cancer patients often have additional conditions documented during evaluation and treatment.

Common Billing Scenarios for Prostate Cancer

Scenario 1: Urology Consultation After Elevated PSA

Documentation:

“Patient referred for PSA elevation. No prostate cancer diagnosis established.”

Possible coding:

• R97.20 — Elevated PSA

Do not code:

• C61

because malignancy has not been confirmed.

Scenario 2: Oncology Visit During Active Treatment

Documentation:

“Patient receiving androgen deprivation therapy for prostate cancer.”

Possible coding:

• C61 — Malignant neoplasm of prostate

Scenario 3: Surveillance After Completed Treatment

Documentation:

“Patient previously treated for prostate cancer. No recurrence.”

Possible coding:

• Z85.46 — Personal history of malignant neoplasm of prostate

Scenario 4: Screening PSA Appointment

Documentation:

“Preventive prostate cancer screening visit.”

Possible coding:

• Z12.5 — Encounter for screening for malignant neoplasm of prostate

How Medical Billing Teams Can Reduce Prostate Cancer Claim Denials

Accurate coding is only one part of successful reimbursement. Revenue cycle teams should also ensure that documentation, authorization, and claim submission processes align.

1. Verify Diagnosis Before Claim Submission

Before billing:

Confirm:

• Diagnosis is documented by the provider
• Code reflects active or historical disease
• Procedure matches diagnosis

2. Avoid Using Screening Codes for Diagnostic Services

A screening diagnosis is not interchangeable with a diagnostic evaluation.

Example:

Incorrect:

PSA abnormality + biopsy billed with screening diagnosis only

Potential issue:

Medical necessity denial

3. Maintain Supporting Documentation

High-cost oncology services may require:

• Office notes
• Pathology reports
• Imaging documentation
• Treatment plans
• Prior authorization records

4. Review Denial Trends

Billing departments should monitor:

• Incorrect diagnosis selection
• Missing documentation
• Authorization failures
• Medical necessity edits

Regular denial analysis helps identify recurring coding issues.

Prostate Cancer ICD-10 Code: Frequently Asked Questions

What is the prostate cancer ICD-10 code?

The primary prostate cancer ICD-10 code is:

C61 — Malignant neoplasm of prostate

This code is used when the provider documents active prostate cancer. It should not be used for screening visits or personal history situations.

What is the ICD-10 code for prostate cancer screening?

The ICD-10 screening for prostate cancer code is:

Z12.5 — Encounter for screening for malignant neoplasm of prostate

This code applies when a patient receives preventive screening without a confirmed prostate cancer diagnosis.

What is the ICD-10 code for history of prostate cancer?

The ICD-10 code for history of prostate cancer is:

Z85.46 — Personal history of malignant neoplasm of prostate

It is used when the patient previously had prostate cancer but no longer has active disease.

What is the neoplasm of prostate ICD-10 code?

The appropriate code depends on whether the neoplasm is malignant, benign, uncertain, or unspecified.

For confirmed prostate cancer:

C61 — Malignant neoplasm of prostate

Other prostate growths require different ICD-10-CM categories based on provider documentation.

Can C61 be used for prostate cancer follow-up visits?

It depends on whether the cancer is still active.

Use:

• C61 when active cancer is present or being treated
• Z85.46 when cancer has been treated and there is no current disease

The medical record should clearly establish the patient’s cancer status.

What is the ICD-10 code for elevated PSA?

The commonly used code is:

R97.20 — Elevated prostate specific antigen [PSA]

An elevated PSA alone does not confirm prostate cancer.

What is the ICD-10 code for metastatic prostate cancer?

Metastatic prostate cancer generally requires:

• C61 — Malignant neoplasm of prostate

plus additional secondary malignancy codes when metastatic sites are documented.

Example:

• C79.51 — Secondary malignant neoplasm of bone

What is the ICD-10 code for colorectal cancer?

The ICD-10 code for colorectal cancer depends on the specific anatomical location.

Examples:

• C18 — Malignant neoplasm of colon
• C19 — Malignant neoplasm of rectosigmoid junction
• C20 — Malignant neoplasm of rectum

Colorectal cancer codes are separate from prostate cancer codes.